This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Andrews, K. L. Articles by Miner, J. H. Search for Related Content PubMed PubMed Citation Articles by Andrews, K. L. Articles by Miner, J. H.

(American Journal of Pathology. 2000;157:303-311.)
© 2000 American Society for Investigative Pathology

Regular Articles

Gelatinase B (MMP-9) Is Not Essential in the Normal Kidney and Does Not Influence Progression of Renal Disease in a Mouse Model of Alport Syndrome

Kaya L. Andrews^*, Tomoko Betsuyaku, Sharon Rogers^*, J. Michael Shipley, Robert M. Senior and Jeffrey H. Miner^*

From the Renal Division^*
and the Division of Pulmonary and Critical Care Medicine,
the Department of Internal Medicine, and the Department of Cell Biology and Physiology,
the Washington University School of Medicine, St. Louis, Missouri

Matrix metalloproteinases are matrix degrading enzymes implicated in many biological processes, including development and inflammation. Gelatinase B (gelB; also known as MMP-9) is expressed in the kidney and is hypothesized to be involved in basement membrane remodeling and in preventing pathogenic accumulation of extracellular matrix in the kidney. Inhibition of gelB activity in metanephric organ culture disrupts branching morphogenesis of the ureteric bud, suggesting that gelB plays a role in kidney development in vivo. We studied kidneys of gelB-deficient mice to search for developmental, histological, molecular, ultrastructural, and functional defects. Surprisingly, no differences between gelB-/- and control kidneys were detected, and renal function was normal in gelB mutants. In addition, gelB-/- embryonic kidneys developed normally in organ culture. Gelatinase B-deficient mice were bred with Col4a3-/- mice, a model for Alport syndrome, to determine whether gelB influences the progression of glomerulonephritis. This is an important question, as it has been hypothesized that proteases are involved in damaging Alport glomerular basement membrane. However, the presence or absence of gelB did not affect the rate of progression of renal disease. Thus, gelB does not have a discernible role in the normal kidney and gelB is not involved in the progression of glomerulonephritis in a mouse model of Alport syndrome.

This article has been cited by other articles:

				C. Arnould, M. Lelievre-Pegorier, P. Ronco, and B. Lelongt MMP9 Limits Apoptosis and Stimulates Branching Morphogenesis During Kidney Development J. Am. Soc. Nephrol., October 1, 2009; 20(10): 2171 - 2180. [Abstract] [Full Text] [PDF]

				D. Cosgrove, D. T. Meehan, D. Delimont, A. Pozzi, X. Chen, K. D. Rodgers, R. M. Tempero, M. Zallocchi, and V. H. Rao Integrin {alpha}1{beta}1 Regulates Matrix Metalloproteinases via P38 Mitogen-Activated Protein Kinase in Mesangial Cells: Implications for Alport Syndrome Am. J. Pathol., March 1, 2008; 172(3): 761 - 773. [Abstract] [Full Text] [PDF]

				A. Dixon and C. Maric 17beta-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-beta protein expression and signaling Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1678 - F1690. [Abstract] [Full Text] [PDF]

				R. V. Sampogna and S. K. Nigam Implications of Gene Networks for Understanding Resilience and Vulnerability in the Kidney Branching Program Physiology, December 1, 2004; 19(6): 339 - 347. [Abstract] [Full Text] [PDF]

				T.-H. Chun, F. Sabeh, I. Ota, H. Murphy, K. T. McDonagh, K. Holmbeck, H. Birkedal-Hansen, E. D. Allen, and S. J. Weiss MT1-MMP-dependent neovessel formation within the confines of the three-dimensional extracellular matrix J. Cell Biol., November 22, 2004; 167(4): 757 - 767. [Abstract] [Full Text] [PDF]

				M. N. Rheault, S. M. Kren, B. K. Thielen, H. A. Mesa, J. T. Crosson, W. Thomas, Y. Sado, C. E. Kashtan, and Y. Segal Mouse Model of X-Linked Alport Syndrome J. Am. Soc. Nephrol., June 1, 2004; 15(6): 1466 - 1474. [Abstract] [Full Text] [PDF]

				Y. S. Kanwar, J. Wada, S. Lin, F. R. Danesh, S. S. Chugh, Q. Yang, T. Banerjee, and J. W. Lomasney Update of extracellular matrix, its receptors, and cell adhesion molecules in mammalian nephrogenesis Am J Physiol Renal Physiol, February 1, 2004; 286(2): F202 - F215. [Abstract] [Full Text] [PDF]

				N. Lods, P. Ferrari, F. J. Frey, A. Kappeler, C. Berthier, B. Vogt, and H.-P. Marti Angiotensin-Converting Enzyme Inhibition but not Angiotensin II Receptor Blockade Regulates Matrix Metalloproteinase Activity in Patients with Glomerulonephritis J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2861 - 2872. [Abstract] [Full Text] [PDF]

				A. Fornoni, Y. Wang, O. Lenz, L. J. Striker, and G. E. Striker Association of a Decreased Number of d(CA) Repeats in the Matrix Metalloproteinase-9 Promoter with Glomerulosclerosis Susceptibility in Mice J. Am. Soc. Nephrol., August 1, 2002; 13(8): 2068 - 2076. [Abstract] [Full Text] [PDF]

				K. L. Andrews, J. L. Mudd, C. Li, and J. H. Miner Quantitative Trait Loci Influence Renal Disease Progression in a Mouse Model of Alport Syndrome Am. J. Pathol., February 1, 2002; 160(2): 721 - 730. [Abstract] [Full Text] [PDF]

				B. LEGALLICIER, G. TRUGNAN, G. MURPHY, B. LELONGT, P. RONCO, and P. FONTANGES Expression of the Type IV Collagenase System during Mouse Kidney Development and Tubule Segmentation J. Am. Soc. Nephrol., November 1, 2001; 12(11): 2358 - 2369. [Abstract] [Full Text] [PDF]

				B. Lelongt, S. Bengatta, M. Delauche, L. R. Lund, Z. Werb, and P. M. Ronco Matrix Metalloproteinase 9 Protects Mice from Anti-Glomerular Basement Membrane Nephritis through Its Fibrinolytic Activity J. Exp. Med., April 2, 2001; 193(7): 793 - 802. [Abstract] [Full Text] [PDF]